📰 Barnaby Balmforth News
Page 2 - Barnaby Balmforth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Barnaby Balmforth. Real-time updates on events, politics, business and more.
February 1, 2022
The UK-based cancer diagnostics company will use the funding to launch ASPYRE-Lung, its pyrophosphorolysis-based lung cancer mutation detection assay.
February 1, 2022
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, has successfully completed a heavily oversubscribed $23 million Series A+ investment...
February 1, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
February 1, 2022
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, has successfully completed a heavily oversubscribed $23 million Series A+ investment...
January 6, 2022
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, has expanded its Scientific Advisory Board to include Lee N. Newcomer, MD, an...
January 6, 2022
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, has expanded its Scientific Advisory Board to include Lee N. Newcomer, MD, an...
November 5, 2021
Lawmakers have acted to strengthen insurance reimbursement for biomarker testing in California, Illinois and Louisiana. Patient advocates and testing companies hope more will act in the coming year.
October 13, 2021
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, today praised California Governor Gavin Newsom and the California legislature for the...
January 28, 2021
· Global clinical lead for the Pfizer SMO Inhibitor, Daurismo, from pre-IND to FDA approval · Clinical development and medical affairs leadership for multiple publicly-traded and private companies Cambridge, UK 28 January 2021 - Biofidelity Ltd, the cancer diagnostics company, today announces the appointment of Wendy J. Levin MD MS as Chief Medical Officer, based in the US. Following Biofidelitys recent Series A finan...
December 10, 2020
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biofidelity appoints Robert Osborne as Chief Operating Officer Biofidelity LimitedDecember 10, 2020 GMT CAMBRIDGE, United Kingdom, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr. Robert Osborne as Chief Operating Officer. In addition to responsibility for the overall operation of...